drugset / Trial / NCT00580398

Smoking Cessation Intervention for Thoracic Patients

NCT00580398

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The primary aim of the proposed study is to develop and assess the feasibility of delivering a smoking cessation intervention to patients undergoing lung surgery that begins before surgery and continues up to 3 months post-discharge. The secondary aim is to assess smoking cessation rates 3 months following surgery.

Timeline

Start
2008-01
Primary completion
2012-04
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Varenicline Small molecule 1 mg

Indications